KUKJEON PHARMACEUTICAL Co., Ltd (KOSDAQ:307750)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,715.00
-105.00 (-2.75%)
At close: Apr 9, 2026

KUKJEON PHARMACEUTICAL Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
201,684168,844172,478306,192324,839537,308
Market Cap Growth
22.88%-2.11%-43.67%-5.74%-39.54%-
Enterprise Value
216,596189,611178,557319,290284,635-
Last Close Price
3755.003365.003515.006222.176590.2610900.81
PE Ratio
--99.3463.4736.30133.06
PS Ratio
1.541.291.262.513.136.30
PB Ratio
2.101.761.773.143.526.46
P/TBV Ratio
2.121.781.803.223.606.50
P/FCF Ratio
26.9122.5382.14---
P/OCF Ratio
19.0115.9217.31--176.63
EV/Sales Ratio
1.651.451.312.622.75-
EV/EBITDA Ratio
83.6571.1932.6333.1157.72-
EV/EBIT Ratio
--486.9249.0581.60-
EV/FCF Ratio
28.9025.3085.04---
Debt / Equity Ratio
0.480.480.670.810.640.09
Debt / EBITDA Ratio
17.2317.2311.948.1712.031.09
Debt / FCF Ratio
6.136.1331.11---
Net Debt / Equity Ratio
0.160.160.190.14-0.39-0.38
Net Debt / EBITDA Ratio
5.775.773.381.45-7.22-4.35
Net Debt / FCF Ratio
2.052.058.81-0.311.224.26
Asset Turnover
0.670.670.620.580.68-
Inventory Turnover
5.025.024.224.054.62-
Quick Ratio
0.820.820.850.941.672.72
Current Ratio
1.131.131.191.242.023.52
Return on Equity (ROE)
-4.98%-4.98%0.55%4.95%10.12%-
Return on Assets (ROA)
-0.82%-0.82%0.10%1.93%1.44%-
Return on Invested Capital (ROIC)
-2.22%-2.26%0.20%7.75%5.15%9.38%
Return on Capital Employed (ROCE)
-2.30%-2.30%0.30%5.20%2.80%7.20%
Earnings Yield
-2.13%-2.55%1.01%1.58%2.76%0.75%
FCF Yield
3.72%4.44%1.22%-14.46%-9.02%-1.37%
Payout Ratio
--28.26%-5.48%-
Buyback Yield / Dilution
-0.77%-0.77%-1.09%4.23%-16.16%-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.